citationStyle,citationStringAnnotated
0,"<author><family>Mehrinfar</family>, <given>Ramona</given> and <family>Shah</family>, <given>Atman Prabodh</given></author> (<issued><year>2009</year></issued>) <title>‚ÄúBivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention.‚Äù</title> <container-title>Cardiovascular Revascularization Medicine</container-title>, <volume>10</volume>(<issue>4</issue>), p. <page>267</page>. [online] Available from: <URL>http://dx.doi.org/10.1016/j.carrev.2009.04.081</URL>"
1,"<author><family>Mehrinfar</family>, <given>Ramona</given> and <family>Shah</family>, <given>Atman Prabodh</given></author> (<issued><year>2009</year></issued>) <title>‚ÄúBivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention.‚Äù</title> <container-title>Cardiovascular Revascularization Medicine</container-title>, <volume>10</volume>(<issue>4</issue>), p. <page>267</page>. [online] Available from: <URL>http://dx.doi.org/10.1016/j.carrev.2009.04.081</URL>"
2,"<author><family>Mehrinfar</family>, <given>R.</given>, & <family>Shah</family>, <given>A. P.</given></author>. <issued><year>2009</year></issued>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title>, <volume>10</volume>(<issue>4</issue>): <page>267</page>."
3,"<author><family>Mehrinfar</family>, <given>R.</given>, <family>Shah</family>, <given>A.P.</given></author>, <issued><year>2009</year></issued>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume> <issue>4</issue> , <page>267</page>. doi:<DOI>10.1016/j.carrev.2009.04.081</DOI>"
4,"<author><family>Mehrinfar</family>, <given>R.</given> and <family>Shah</family>, <given>A.P.</given></author> <issued><year>2009</year></issued>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title>. <volume>10</volume>, <issue>4</issue> (<issued><month>Oct.</month> <year>2009</year></issued>), <page>267</page>. DOI:https://doi.org/<DOI>10.1016/j.carrev.2009.04.081</DOI>."
5,"<author><given>Ramona</given> <family>Mehrinfar</family> and <given>Atman Prabodh</given> <family>Shah</family></author>. <issued><year>2009</year></issued>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume>, <issue>4</issue>: <page>267</page>."
6,"<author><family>Mehrinfar</family>, <given>R.</given>; <family>Shah</family>, <given>A.P.</given></author>. <issued><year>2009</year></issued>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume>: <page>267</page>."
7,"<author><family>Mehrinfar</family> <given>R</given>, <family>Shah</family> <given>AP</given></author>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> [Internet] <issued><year>2009</year></issued> ; <volume>10</volume>: <page>267</page>. Available from: <URL>http://dx.doi.org/10.1016/j.carrev.2009.04.081</URL>"
8,"<author><family>Mehrinfar</family> <given>Ramona</given>, <family>Shah</family> <given>Atman Prabodh</given></author>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <issued><year>2009</year></issued>;<volume>10</volume>(<issue>4</issue>):<page>267</page>. Doi: <DOI>10.1016/j.carrev.2009.04.081</DOI>."
9,"<author><family>Mehrinfar</family> <given>R</given>., <family>Shah</family> <given>AP</given>.</author> <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <issued><year>2009</year></issued>;<volume>10</volume>(<issue>4</issue>):<page>267</page>. Doi: <DOI>10.1016/j.carrev.2009.04.081</DOI>."
10,"<author><given>R.</given> <family>Mehrinfar</family> and <given>A. P.</given> <family>Shah</family></author>, <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>, <container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume> (<issued><year>2009</year></issued>) <page>267</page>.; DOI:<DOI>10.1016/j.carrev.2009.04.081</DOI>"
11,"<author><family>Mehrinfar</family> <given>R</given>, <family>Shah</family> <given>AP</given></author>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <issued><year>2009</year></issued>;<volume>10</volume>:<page>267</page>."
12,"<author><family>Mehrinfar</family>, <given>R.</given> & <given>A.P.</given> <family>Shah</family></author>. <issued>2009</issued>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title>. <volume>10</volume>(<issue>4</issue>): <page>267</page>."
13,"<author><family>Mehrinfar</family>, <given>R.</given>, <family>Shah</family>, <given>A. P.</given></author> <issued><year>2009</year></issued>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title>, <volume>10</volume>(<issue>4</issue>):<page>267</page>."
14,<author><family>Mehrinfar</family> <given>R</given> & <family>Shah</family> <given>AP</given></author> (<issued><year>2009</year></issued>) <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume>:<page>267</page>.
15,"<author><family>Mehrinfar</family>, <given>R.</given>, and <given>A. P.</given> <family>Shah</family></author><issued><year>2009</year></issued> <title>‚ÄúBivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention.‚Äù</title> <container-title>Cardiovascular Revascularization Medicine</container-title>, <volume>10</volume>: <page>267</page>. <publisher>Elsevier BV</publisher>."
16,"<author><given>R.</given> <family>Mehrinfar</family>, <given>A. P.</given> <family>Shah</family></author>, <container-title>Cardiovascular Revascularization Medicine</container-title> <issued><year>2009</year></issued>, <volume>10</volume>, <page-first>267</page-first>."
17,"<author><family>Mehrinfar</family>, <given>R.</given>, and <family>Shah</family>, <given>A. P.</given></author>, <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>, <container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume> (<issued><year>2009</year></issued>) <page>267</page>."
18,"<author><family>Mehrinfar</family>, <given>R.</given> and <family>Shah</family>, <given>A.P.</given></author> (<issued><year>2009</year></issued>). <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title>, <volume>10</volume>(<issue>4</issue>):<page>267</page>."
19,"<author><family>Mehrinfar</family>, <given>R.</given> & <family>Shah</family>, <given>A.P.</given></author>, <issued><year>2009</year></issued>, <title>‚ÄúBivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention,‚Äù</title> <container-title>Cardiovascular Revascularization Medicine</container-title>, <volume>10</volume>(<issue>4</issue>), <page>267</page>."
20,"<author><family>Mehrinfar</family>, <given>R.</given> and <family>Shah</family>, <given>A. P.</given></author> <issued><year>2009</year></issued>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title>, <volume>10</volume>, <issue>4</issue>, <page>267</page>."
21,"<author><family>Mehrinfar</family> <given>R</given>, <family>Shah</family> <given>AP</given></author>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> [Internet]. <publisher>Elsevier BV</publisher>; <issued><year>2009</year></issued>; <volume>10</volume>: <page>267</page>. Available from: <URL>http://dx.doi.org/10.1016/j.carrev.2009.04.081</URL>"
22,"<author><family>Mehrinfar</family> <given>R</given>., <family>Shah</family> <given>AP</given>.</author> <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <issued><year>2009</year></issued>;<volume>10</volume>(<issue>4</issue>):<page>267</page>. Doi: <DOI>10.1016/j.carrev.2009.04.081</DOI>."
23,"<author><family>Mehrinfar</family>, <given>R.</given>, and <given>A. P.</given> <family>Shah</family></author>. <issued><year>2009</year></issued>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume>. <publisher>Elsevier BV</publisher>: <page>267</page>. doi:<DOI>10.1016/j.carrev.2009.04.081</DOI>."
24,"<author><family>Mehrinfar</family> <given>R</given>, <family>Shah</family> <given>AP</given></author>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> [Internet]. <publisher>Elsevier BV</publisher>; <issued><year>2009</year></issued>;<volume>10</volume>:<page>267</page>. Available from: <URL>http://dx.doi.org/10.1016/j.carrev.2009.04.081</URL>"
25,"<author><family>Mehrinfar</family>, <given>R.</given>, and <given>A. P.</given> <family>Shah</family></author>, <issued><year>2009</year></issued>, <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>: <container-title>Cardiovascular Revascularization Medicine</container-title>, v. <volume>10</volume>, no. <issue>4</issue>, p. <page>267</page>, doi:<DOI>10.1016/j.carrev.2009.04.081</DOI>."
26,"<author><family>Mehrinfar</family>, <given>R.</given>; <family>Shah</family>, <given>A. P.</given></author>. <title>Bivalirudin versus Heparin and Eptifibatide in Patients Undergoing Rescue Percutaneous Coronary Intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <issued><year>2009</year></issued>, <volume>10</volume> (<issue>4</issue>), <page>267</page>."
27,"<author><family>Mehrinfar</family>, <given>R.</given>, & <family>Shah</family>, <given>A. P.</given></author>. (<issued><year>2009</year></issued>). <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title>, <volume>10</volume>(<issue>4</issue>), <page>267</page>. https://doi.org/<DOI>10.1016/j.carrev.2009.04.081</DOI>"
28,"<author><family>Mehrinfar</family>, <given>R.</given>, and <given>A.P.</given> <family>Shah</family></author>. <issued><year>2009</year>. <month>October</month></issued>. <title>‚ÄúBivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention‚Äù</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume> <issue>4</issue> (<issued><month>October</month></issued>): <page>267</page>. doi:<DOI>10.1016/j.carrev.2009.04.081</DOI>. <URL>http://dx.doi.org/10.1016/j.carrev.2009.04.081</URL>."
29,"<author><family>Mehrinfar</family> <given>R</given>, <family>Shah</family> <given>AP</given></author>. <issued><year>2009</year></issued>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume>: <page>267</page>."
30,"<author><family>Mehrinfar</family> <given>R</given>, <family>Shah</family> <given>AP</given></author>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <issued><year>2009</year></issued>;<volume>10</volume>(<issue>4</issue>):<page>267</page>. Available at: <URL>http://dx.doi.org/10.1016/j.carrev.2009.04.081</URL>."
31,"<author><family>Mehrinfar</family>, <given>Ramona</given>, and <given>Atman Prabodh</given> <family>Shah</family></author>. <issued><year>2009</year></issued>. <title>‚ÄúBivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention.‚Äù</title> <container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume>(<issue>4</issue>): <page>267</page>. <URL>http://dx.doi.org/10.1016/j.carrev.2009.04.081</URL>."
32,"<author><family>Mehrinfar</family>, <given>R.</given>, and <family>Shah</family>, <given>A. P.</given></author>, <issued><year>2009</year></issued>, <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>: <container-title>Cardiovascular Revascularization Medicine</container-title>, v. <volume>10</volume>, p. <page>267</page>."
33,"<author><family>Mehrinfar</family> <given>R</given>, <family>Shah</family> <given>AP</given></author>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <issued><year>2009</year></issued>; <volume>10</volume>:<page>267</page>."
34,"<author><family>Mehrinfar</family>, <given>Ramona</given> and <given>Atman Prabodh</given> <family>Shah</family></author> (<issued><year>2009</year></issued>), <title>‚ÄúBivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention,‚Äù</title> <container-title>Cardiovascular Revascularization Medicine</container-title>, <volume>10</volume> (<issue>4</issue>), <page>267</page>."
35,"<author><family>Mehrinfar</family> <given>R</given>, <family>Shah</family> <given>AP</given></author>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title>. <issued><year>2009</year></issued>;<volume>10</volume>(<issue>4</issue>):<page>267</page>. doi:<DOI>10.1016/j.carrev.2009.04.081</DOI>."
36,"<author><family>Mehrinfar</family>, <given>R.</given>, and <given>A. P.</given> <family>Shah</family></author>, <issued><year>2009</year></issued>: <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title>, <volume>10</volume>, <page>267</page>, doi:<DOI>10.1016/j.carrev.2009.04.081</DOI>. <URL>http://dx.doi.org/10.1016/j.carrev.2009.04.081</URL>."
37,"<author><given>R.</given> <family>Mehrinfar</family> and <given>A. P.</given> <family>Shah</family></author>, <container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume>, <page-first>267</page-first> (<issued><year>2009</year></issued>)."
38,"<author><family>Mehrinfar</family> <given>R</given>, <family>Shah</family> <given>AP</given></author>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume>: <page>267</page>, <issued><year>2009</year></issued>."
39,"<author><family>Mehrinfar</family>, <given>R.</given>, and <family>Shah</family>, <given>A. P.</given></author>. <issued><year>2009</year></issued>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title>. <volume>10</volume>:<page>267</page> Available at: <URL>http://dx.doi.org/10.1016/j.carrev.2009.04.081</URL>."
40,"<author><family>Mehrinfar</family>, <given>Ramona</given>, and <given>Atman Prabodh</given> <family>Shah</family></author>. <issued><year>2009</year></issued>. <title>‚ÄúBivalirudin versus Heparin and Eptifibatide in Patients Undergoing Rescue Percutaneous Coronary Intervention.‚Äù</title> <container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume>(<issue>4</issue>): <page>267</page>. <URL>http://dx.doi.org/10.1016/j.carrev.2009.04.081</URL>."
41,"<author><family>Mehrinfar</family> <given>R</given>, <family>Shah</family> <given>AP</given></author>. <issued><year>2009</year></issued>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume>:<page>267</page>."
42,"<author><family>Mehrinfar</family> <given>R</given>, and <family>Shah</family> <given>AP</given></author> (<issued><year>2009</year></issued>) <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume>:<page>267</page>, <publisher>Elsevier BV</publisher>."
43,"<author><family>Mehrinfar</family>, <given>R.</given>, <family>Shah</family>, <given>A. P.</given></author>. (<issued><year>2009</year></issued>). <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title>, <volume>10</volume>(<issue>4</issue>), <page>267</page>. https://doi.org/<DOI>10.1016/j.carrev.2009.04.081</DOI>"
44,"<author><family>Mehrinfar</family>, <given>R.</given>, and <family>Shah</family>, <given>A. P.</given></author>. (<issued><year>2009</year></issued>). <title>‚ÄúBivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention.‚Äù</title> <container-title>Cardiovascular Revascularization Medicine</container-title>, <publisher>Elsevier BV</publisher>, <volume>10</volume>(<issue>4</issue>), <page>267</page>."
45,"<author><family>Mehrinfar</family>, <given>R.</given>, and <family>Shah</family>, <given>A. P.</given></author>, <issued><year>2009</year></issued>, <title>‚ÄúBivalirudin versus Heparin and Eptifibatide in Patients Undergoing Rescue Percutaneous Coronary Intervention,‚Äù</title> <container-title>Cardiovascular Revascularization Medicine</container-title>, <volume>10</volume>(<issue>4</issue>), p. <page>267</page>."
46,"<author><family>Mehrinfar</family>, <given>Ramona</given> and <given>Atman Prabodh</given> <family>Shah</family></author>. <issued>2009</issued>. <title>‚ÄúBivalirudin versus Heparin and Eptifibatide in Patients Undergoing Rescue Percutaneous Coronary Intervention.‚Äù</title> <container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume>(<issue>4</issue>):<page>267</page>."
47,"<author><family>Mehrinfar</family>, <given>R.</given>, and <family>Shah</family>, <given>A. P.</given></author> (<issued><year>2009</year></issued>), <title>‚ÄúBivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention,‚Äù</title> <container-title>Cardiovascular Revascularization Medicine</container-title>, <publisher>Elsevier BV</publisher>, <volume>10</volume>, <page>267</page>. https://doi.org/<DOI>10.1016/j.carrev.2009.04.081</DOI>."
48,"<author><family>Mehrinfar</family> <given>R</given>, <family>Shah</family> <given>AP</given></author>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <issued><year>2009</year></issued>;<volume>10</volume>:<page>267</page>. Available at: <URL>http://dx.doi.org/10.1016/j.carrev.2009.04.081</URL>."
49,"<author><family>Mehrinfar</family>, <given>R.</given>, <family>Shah</family>, <given>A.P.</given></author> (<issued><year>2009</year></issued>): <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume>: <page>267</page>."
50,"<author><family>Mehrinfar</family> <given>Ramona</given>, <family>Shah</family> <given>Atman Prabodh</given></author>, ‚Äú<title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>,‚Äù <container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume>.<issue>4</issue> (<issued><year>2009</year></issued>) (url = <URL>http://dx.doi.org/10.1016/j.carrev.2009.04.081</URL>), p.¬†<page>267</page>."
51,"<author><family>Mehrinfar</family> <given>R</given>, <family>Shah</family> <given>AP</given></author>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <issued><year>2009</year></issued>; <volume>10</volume>: <page>267</page>."
52,"<author><given>R.</given> <family>Mehrinfar</family> and <given>A. P.</given> <family>Shah</family></author>, <container-title>Cardiovascular Revascularization Medicine</container-title>, <issued><year>2009</year></issued>, <volume>10</volume>, <page-first>267</page-first>."
53,"<author><family>Mehrinfar</family> <given>R</given>, <family>Shah</family> <given>AP</given></author>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <issued><year>2009</year></issued>;<volume>10</volume>:<page>267</page>. Available at: <URL>http://dx.doi.org/10.1016/j.carrev.2009.04.081</URL>."
54,"<author><family>Mehrinfar</family> <given>R</given>, <family>Shah</family> <given>AP</given></author>: <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <issued><year>2009</year></issued>; <volume>10</volume>:<page>267</page>"
55,"<author><given>R.</given> <family>Mehrinfar</family>, <given>A. P.</given> <family>Shah</family></author>, <container-title>Cardiovascular Revascularization Medicine</container-title> <issued><year>2009</year></issued>, <volume>10</volume>, <page>267</page>."
56,"<author><family>Mehrinfar</family> <given>R</given>., <family>Shah</family> <given>AP</given>.</author> <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title>. <issued><year>2009</year></issued>;<volume>10</volume>(<issue>4</issue>):<page>267</page>, Doi: <DOI>10.1016/j.carrev.2009.04.081</DOI>."
57,"<author><family>Mehrinfar</family>, <given>R.</given>, & <family>Shah</family>, <given>A. P.</given></author>. (<issued><year>2009</year></issued>). <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume>, <page>267</page>."
58,"<author><family>Mehrinfar</family> <given>R.</given>, <family>Shah</family> <given>A.P.</given></author>, <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>, <container-title>Cardiovascular Revascularization Medicine</container-title>, <issued><year>2009</year></issued>, <volume>10</volume>, <page>267</page>"
59,"<author><family>Mehrinfar</family> <given>R</given> and <family>Shah</family> <given>AP</given></author> <issued><year>2009</year></issued>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume>, <page>267</page>."
60,"<author><family>Mehrinfar</family>, <given>R.</given> & <family>Shah</family>, <given>A.P.</given></author> (<issued><year>2009</year></issued>): <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. ‚Äì <container-title>Cardiovascular Revascularization Medicine</container-title>, <volume>10</volume>/<issue>4</issue>: <page>267</page> (<publisher>Elsevier BV</publisher>). doi: <DOI>10.1016/j.carrev.2009.04.081</DOI>."
61,"<author><family>Mehrinfar</family> <given>R.</given>, <family>Shah</family> <given>A.P.</given></author> (<issued><year>2009</year></issued>) <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title>, <volume>10</volume>, <page>267</page>. Available at: <URL>http://dx.doi.org/10.1016/j.carrev.2009.04.081</URL>."
62,"<author><family>Mehrinfar</family> <given>R</given>, <family>Shah</family> <given>AP</given></author>: <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title>. <issued><year>2009</year></issued>; <volume>10</volume>:<page>267</page>."
63,"<author><family>Mehrinfar</family>, <given>R.</given>, and <given>A. P.</given> <family>Shah</family></author>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume>:<page>267</page>, <issued><year>2009</year></issued>."
64,"<author><family>Mehrinfar</family> <given>R</given>, <family>Shah</family> <given>AP</given></author>. <issued><year>2009</year></issued>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume>: <page>267</page>."
65,"<author><family>Mehrinfar</family> <given>R</given>, <family>Shah</family> <given>AP</given></author>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <issued><year>2009</year></issued>;<volume>10</volume>:<page>267</page>."
66,"<author><family>Mehrinfar</family> <given>R</given>, <family>Shah</family> <given>AP</given></author>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title> [Internet]. <container-title>Cardiovascular Revascularization Medicine</container-title> <issued><year>2009</year></issued>;<volume>10</volume>(<issue>4</issue>):<page>267</page>.Available from: <URL>http://dx.doi.org/10.1016/j.carrev.2009.04.081</URL>"
67,"<author><family>Mehrinfar</family> <given>R</given>, <family>Shah</family> <given>AP</given></author>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <issued><year>2009</year></issued>; <volume>10</volume>(<issue>4</issue>):<page>267</page>."
68,"<author><family>Mehrinfar</family> <given>R</given>, <family>Shah</family> <given>AP</given></author>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title>. <issued>2009</issued>;<volume>10</volume>:<page>267</page>."
69,"<author><family>Mehrinfar</family>, <given>R.</given>, and <given>A. P.</given> <family>Shah</family></author>. <issued><year>2009</year></issued>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume> (<issue>4</issue>):<page>267</page>. <URL>http://dx.doi.org/10.1016/j.carrev.2009.04.081</URL>."
70,<author><family>Mehrinfar</family> <given>R.</given> & <given>A.P.</given> <family>Shah</family></author>. <issued><year>2009</year></issued>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume>: <page>267</page>.
71,"<author><family>Mehrinfar</family> <given>R</given>, <family>Shah</family> <given>AP</given></author>. <issued><year>2009</year></issued>. <container-title>Cardiovascular Revascularization Medicine</container-title>. <volume>10</volume>(<issue>4</issue>):<page>267</page>"
72,"<author><family>Mehrinfar</family> <given>R</given>, <family>Shah</family> <given>AP</given></author>. <issued><year>2009</year></issued>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title>. <volume>10</volume>(<issue>4</issue>):<page>267</page>"
73,"<author><family>Mehrinfar</family> <given>R</given>, <family>Shah</family> <given>AP</given></author>. <container-title>Cardiovascular Revascularization Medicine</container-title>. <volume>10</volume>(<issue>4</issue>):<page-first>267</page-first>. (<issued><year>2009</year></issued>)"
74,"<author><family>Mehrinfar</family> <given>R</given>, <family>Shah</family> <given>AP</given></author>. <issued><year>2009</year></issued>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title>. <volume>10</volume>(<issue>4</issue>):<page>267</page>"
75,"<author><family>Mehrinfar</family> <given>R</given>, <family>Shah</family> <given>AP</given></author>. <issued><year>2009</year></issued>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title>. <volume>10</volume>(<issue>4</issue>):<page>267</page>"
76,"<author><family>Mehrinfar</family> <given>R</given>, <family>Shah</family> <given>AP</given></author>. <issued><year>2009</year></issued>. <container-title>Cardiovascular Revascularization Medicine</container-title>. <volume>10</volume>(<issue>4</issue>):<page>267</page>"
77,"<author><family>Mehrinfar</family> <given>R</given>, <family>Shah</family> <given>AP</given></author>. <issued><year>2009</year></issued>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title>. <volume>10</volume>(<issue>4</issue>):<page>267</page>"
78,"<author><family>Mehrinfar</family>, <given>R.</given> & <family>Shah</family>, <given>A.P.</given></author>. <issued>2009</issued>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title>, <volume>10</volume>, <page>267</page>, <DOI>10.1016/j.carrev.2009.04.081</DOI>."
79,"<author><family>MEHRINFAR</family> <given>R.</given> and <given>A.P.</given> <family>SHAH</family></author>, <issued><year>2009</year></issued>, <title>‚ÄúBivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention,‚Äù</title> <container-title>Cardiovascular Revascularization Medicine</container-title>, <volume>10</volume>, (<issue>4</issue>) : <page>267</page>."
80,"<author><family>Mehrinfar</family> <given>R</given> and <family>Shah</family> <given>AP</given></author>: <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume>: <page>267</page>, <issued><year>2009</year></issued>."
81,"<author><family>Mehrinfar</family>, <given>R.</given>. & <given>A.P.</given> <family>Shah</family>.</author> <issued><year>2009</year></issued>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title> <container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume>. <publisher>Elsevier BV</publisher>: <page>267</page>. <URL>http://dx.doi.org/10.1016/j.carrev.2009.04.081</URL>."
82,"<author><family>Mehrinfar</family>, <given>R.</given>, & <family>Shah</family>, <given>A. P.</given></author>. (<issued><year>2009</year></issued>). <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title>, <volume>10</volume>(<issue>4</issue>), <page>267</page>. <publisher>Elsevier BV</publisher>. Retrieved from <URL>http://dx.doi.org/10.1016/j.carrev.2009.04.081</URL>"
83,"<author><family>Mehrinfar</family>, <given>R.</given>, & <family>Shah</family>, <given>A. P.</given></author>. (<issued><year>2009</year></issued>). <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title>, <volume>10</volume>(<issue>4</issue>), <page>267</page>. https://doi.org/<DOI>10.1016/j.carrev.2009.04.081</DOI>"
84,"<author><family>Mehrinfar</family>, <given>R.</given>, & <family>Shah</family>, <given>A. P.</given></author>. (<issued><year>2009</year></issued>). <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title>, <volume>10</volume>(<issue>4</issue>), <page>267</page>. https://doi.org/<DOI>10.1016/j.carrev.2009.04.081</DOI>"
85,"<author><family>Mehrinfar</family>, <given>R.</given>, & <family>Shah</family>, <given>A. P.</given></author>. (<issued><year>2009</year></issued>). <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title>, <volume>10</volume>(<issue>4</issue>), <page>267</page>. https://doi.org/<DOI>10.1016/j.carrev.2009.04.081</DOI>"
86,"<author><family>Mehrinfar</family>, <given>R.</given>, and <family>Shah</family>, <given>A. P.</given></author>. (<issued><year>2009</year></issued>). <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title>, <volume>10</volume>(<issue>4</issue>), <page>267</page>. https://doi.org/<DOI>10.1016/j.carrev.2009.04.081</DOI>"
87,"<author><family>Mehrinfar</family>, <given>R.</given>, & <family>Shah</family>, <given>A. P.</given></author>. (<issued><year>2009</year></issued>). <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title>, <volume>10</volume>, <page>267</page>."
88,"<author><family>Mehrinfar</family>, <given>R.</given>, & <family>Shah</family>, <given>A. P.</given></author>. (<issued><year>2009</year></issued>). <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title>, <volume>10</volume>(<issue>4</issue>), <page>267</page>. doi:<DOI>10.1016/j.carrev.2009.04.081</DOI>"
89,"<author><family>Mehrinfar</family>, <given>R.</given>, & <family>Shah</family>, <given>A. P.</given></author>. (<issued><year>2009</year></issued>). <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title>, <volume>10</volume>(<issue>4</issue>), <page>267</page>. https://doi.org/<DOI>10.1016/j.carrev.2009.04.081</DOI> (Original work published)"
90,"<author><family>Mehrinfar</family>, <given>R.</given> and <family>Shah</family>, <given>A. P.</given></author>. (<issued><year>2009</year></issued>). <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title>, <volume>10</volume>(<issue>4</issue>), <page>267</page>. doi:<DOI>10.1016/j.carrev.2009.04.081</DOI>"
91,"<author><family>Mehrinfar</family>, <given>R.</given>, & <family>Shah</family>, <given>A. P.</given></author>. (<issued><year>2009</year></issued>). <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title>, <volume>10</volume>(<issue>4</issue>), <page>267</page>. https://doi.org/<DOI>10.1016/j.carrev.2009.04.081</DOI>"
92,"<author><family>Mehrinfar</family> <given>R</given>, <family>Shah</family> <given>AP</given></author>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <issued><year>2009</year></issued>:<volume>10</volume>;<page>267</page>."
93,"<author><family>Mehrinfar</family>, <given>R.</given>, and <family>Shah</family>, <given>A. P.</given></author>. (<issued><year>2009</year></issued>) <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume> (<issue>4</issue>): <page>267</page>."
94,"<author><given>R.</given> <family>Mehrinfar</family>, <given>A.P.</given> <family>Shah</family></author>. <title>‚ÄúBivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention‚Äù</title>. <container-title>Cardiovascular Revascularization Medicine</container-title>. <publisher>Elsevier BV</publisher>, <issued><year>2009</year></issued>. <volume>10</volume>(<issue>4</issue>): <page>267</page>. <DOI>10.1016/j.carrev.2009.04.081</DOI>."
95,"<author><family>Mehrinfar</family> <given>R</given>, <family>Shah</family> <given>AP</given></author>. <issued><year>2009</year></issued>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume>: <page>267</page>."
96,"<author><family>Mehrinfar</family> <given>R</given>, <family>Shah</family> <given>AP</given></author> (<issued><year>2009</year></issued>) <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume>(<issue>4</issue>)<publisher>Elsevier BV</publisher>, : <page>267</page>, doi: <DOI>10.1016/j.carrev.2009.04.081</DOI>"
97,"<author><family>Mehrinfar</family> <given>R.</given>, <family>Shah</family> <given>A.P.</given></author>, <issued><year>2009</year></issued>, <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume>, <page>267</page>."
98,"<author><family>Mehrinfar</family>, <given>R.</given> and <family>Shah</family>, <given>A.P.</given></author>  (<issued>2009</issued>) : <title>‚ÄúBivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention‚Äù</title>, <container-title>Cardiovascular Revascularization Medicine</container-title>, <volume>10</volume>, <issue>4</issue>, <page>267</page>."
99,"<author><family>Mehrinfar</family>, <given>R.</given> & <given>A.P.</given> <family>Shah</family></author> <issued>(<year>2009</year>):</issued> <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> (<volume>10</volume>)<issue>4</issue>: <page>267</page>. "
100,"<author><family>MEHRINFAR</family>, <given>R.</given> & <given>A.P.</given> <family>SHAH</family></author> <issued><year>2009</year>:</issued> <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume>: <page>267</page>. "
101,"<author><family>Mehrinfar</family>, <given>R.</given>, and <family>Shah</family>, <given>A. P.</given></author>, <issued><year>2009</year></issued>, <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>, <container-title>Cardiovascular Revascularization Medicine</container-title>, <volume>10</volume>(<issue>4</issue>), <page>267</page>."
102,"<author><family>Mehrinfar</family>, <family>Shah</family></author> <issued><year>2009</year></issued>: <author><given>R.</given> <family>Mehrinfar</family>, <given>A.P.</given> <family>Shah</family></author>, ¬´<title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>,¬ª in <container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume>, <issue>4</issue> &lt;<URL>http://dx.doi.org/10.1016/j.carrev.2009.04.081</URL>&gt;, <issued><year>2009</year></issued>, p. <page>267</page>."
103,"<author><family>Mehrinfar</family> <given>R.</given> and <family>Shah</family> <given>A.P.</given></author>	<issued><year>2009</year></issued>, ‚Äú<title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>,‚Äù <container-title>Cardiovascular Revascularization Medicine</container-title>, <volume>10</volume>, <issue>4</issue>, p.¬†<page>267</page>."
104,"<author><family>Mehrinfar</family> <given>R.</given> and <family>Shah</family> <given>A.P.</given></author>, <issued>2009</issued>. <title>‚ÄúBivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention‚Äù</title>, <container-title>Cardiovascular Revascularization Medicine</container-title>, vol. <volume>10</volume>, no. <issue>4</issue>, <issued>October 2009</issued>, <publisher>Elsevier BV</publisher>, p. <page>267</page>, ISSN: <ISSN>1553-8389</ISSN> &lt;DOI: <DOI>10.1016/j.carrev.2009.04.081</DOI>. URL: <URL>http://dx.doi.org/10.1016/j.carrev.2009.04.081</URL>&gt;"
105,"<author><family>Mehrinfar</family>/<family>Shah</family></author>, <container-title>Cardiovascular Revascularization Medicine</container-title>, <volume>10</volume> (<issued><year>2009</year></issued>), <page-first>267</page-first> ff"
106,"<author><family>Mehrinfar</family>, <given>R</given> and <family>Shah</family>, <given>A P</given></author>. <issued><year>2009</year></issued>. <title>‚ÄúBivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention‚Äù</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume>.<issue>4</issue>, <page>267</page>. <URL>http://dx.doi.org/10.1016/j.carrev.2009.04.081</URL>."
107,"<author><family>Mehrinfar</family> <given>R</given>, <family>Shah</family> <given>AP</given></author>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> [Internet]. <issued><year>2009</year></issued>;<volume>10</volume>:<page>267</page>. Available from: <URL>http://dx.doi.org/10.1016/j.carrev.2009.04.081</URL>"
108,"<author><family>Mehrinfar</family> <given>R</given>, <family>Shah</family> <given>AP</given></author>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <issued><year>2009</year></issued>;<volume>10</volume>:<page>267</page>."
109,"<author><family>Mehrinfar</family> <given>R</given>., <family>Shah</family> <given>AP</given>.</author> <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title>. <issued><year>2009</year></issued>;<volume>10</volume>(<issue>4</issue>):<page>267</page>, doi: <DOI>10.1016/j.carrev.2009.04.081</DOI>."
110,"<author><family>Mehrinfar</family>, <given>R.</given>, and <family>Shah</family>, <given>A. P.</given></author>. <issued><year>2009</year></issued>: <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title>, <volume>10</volume>: <page>267</page>, doi: https://doi.org/<DOI>10.1016/j.carrev.2009.04.081</DOI>."
111,"<author><family>Mehrinfar</family> <given>R</given>, <family>Shah</family> <given>AP</given></author>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <issued><year>2009</year></issued>;<volume>10</volume>:<page>267</page>. doi:<DOI>10.1016/j.carrev.2009.04.081</DOI>."
112,"<author><family>Mehrinfar</family> <given>R</given>., <family>Shah</family> <given>AP</given>.</author> <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <issued><year>2009</year></issued>;<volume>10</volume>(<issue>4</issue>):<page>267</page>. Doi: <DOI>10.1016/j.carrev.2009.04.081</DOI>."
113,"<author><family>Mehrinfar</family> <given>R</given>, <family>Shah</family> <given>AP</given></author>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <issued><year>2009</year></issued>;<volume>10</volume>:<page>267</page>. Available at: <URL>http://dx.doi.org/10.1016/j.carrev.2009.04.081</URL>."
114,"<author><family>Mehrinfar</family>, <given>R.</given> and <family>Shah</family>, <given>A.P.</given></author> (<issued><year>2009</year></issued>). <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title>. <publisher>Elsevier BV</publisher>. Vol. 10 No. 4. p. <page>267</page> [online]. https://doi.org/<DOI>10.1016/j.carrev.2009.04.081</DOI>."
115,"<author><family>Mehrinfar</family> <given>R</given>, <family>Shah</family> <given>AP</given></author>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> [Internet]. <issued><year>2009</year></issued>;<volume>10</volume>(<issue>4</issue>):<page>267</page>. Available from: <URL>http://dx.doi.org/10.1016/j.carrev.2009.04.081</URL>"
116,"<author><family>Mehrinfar</family>, <given>R.</given>, and <given>A.P.</given> <family>Shah</family></author>. <issued><year>2009</year></issued>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume>(<issue>4</issue>): <page>267</page>. doi: <DOI>10.1016/j.carrev.2009.04.081</DOI>."
117,"<author><family>Mehrinfar</family> <given>R</given>, <family>Shah</family> <given>AP</given></author>: <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title> <container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume>: <page>267</page>, <issued><year>2009</year></issued>"
118,"<author><family>Mehrinfar</family> <given>R</given>, <family>Shah</family> <given>AP</given></author> (<issued><year>2009</year></issued>) <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume>, <page>267</page>. <URL>http://dx.doi.org/10.1016/j.carrev.2009.04.081</URL>."
119,"<author><family>Mehrinfar</family> <given>R</given> and <given>AP</given> <family>Shah</family></author> (<issued><year>2009</year></issued>) <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume>(<issue>4</issue>), <page>267</page>. https://doi.org/<DOI>10.1016/j.carrev.2009.04.081</DOI>"
120,"<author><family>Mehrinfar</family> <given>R</given>, <family>Shah</family> <given>AP</given></author>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> [Internet] <issued><year>2009</year></issued>;<volume>10</volume>:<page>267</page>. Available from: <URL>http://dx.doi.org/10.1016/j.carrev.2009.04.081</URL>"
121,"<author><family>Mehrinfar</family>, <given>Ramona</given>, and <given>Atman Prabodh</given> <family>Shah</family></author> (<issued><year>2009</year></issued>) <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume>. (<publisher>Elsevier BV</publisher>), p. <page>267</page>. Available at <URL>http://dx.doi.org/10.1016/j.carrev.2009.04.081</URL>."
122,"<author><family>Mehrinfar</family> <given>R</given>, <family>Shah</family> <given>AP</given></author>: <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <issued><year>2009</year></issued>;<volume>10</volume>:<page>267</page>."
123,"<author><family>MEHRINFAR</family>, <given>Ramona</given> e <family>SHAH</family>, <given>Atman Prabodh</given></author>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title>, v. <volume>10</volume>, n. <issue>4</issue>, p. <page>267</page>, <issued><month>Oct.</month> <year>2009</year></issued>. Dispon√≠vel em: &lt;<URL>http://dx.doi.org/10.1016/j.carrev.2009.04.081.</URL>&gt;"
124,"<author><family>MEHRINFAR</family>, <given>Ramona</given>; <family>SHAH</family>, <given>Atman Prabodh</given></author>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title>, v. <volume>10</volume>, n. <issue>4</issue>, p. <page>267</page>, <issued><month>Oct.</month> <year>2009</year></issued>. Dispon√≠vel em: &lt;<URL>http://dx.doi.org/10.1016/j.carrev.2009.04.081.</URL>&gt;"
125,"<author><family>MEHRINFAR</family>, <given>R.</given>; <family>SHAH</family>, <given>A. P.</given></author>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title>, v. <volume>10</volume>, n. <issue>4</issue>, p. <page>267</page>, <issued><month>Oct.</month> <year>2009</year></issued>. "
126,"<author><family>MEHRINFAR</family>, <given>Ramona</given> and <family>SHAH</family>, <given>Atman Prabodh</given></author>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title>, vol.¬†<volume>10</volume>, no.¬†<issue>4</issue>, p.¬†<page>267</page>, <issued><year>2009</year></issued>. Dispon√≠vel em: &lt;<URL>http://dx.doi.org/10.1016/j.carrev.2009.04.081</URL>&gt;."
127,"<author><family>MEHRINFAR</family>, <given>Ramona</given>; <family>SHAH</family>, <given>Atman Prabodh</given></author>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title>, v. <volume>10</volume>, n. <issue>4</issue>, p. <page>267</page>, <issued><month>Oct.</month> <year>2009</year></issued>. Dispon√≠vel em: &lt;<URL>http://dx.doi.org/10.1016/j.carrev.2009.04.081.</URL>&gt;"
128,"<author><family>MEHRINFAR</family>, <given>R.</given>; <family>SHAH</family>, <given>A. P.</given></author>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title>, v. <volume>10</volume>, n. <issue>4</issue>, p. <page>267</page>, <issued><month>Oct.</month> <year>2009</year></issued>. Dispon√≠vel em: &lt;<URL>http://dx.doi.org/10.1016/j.carrev.2009.04.081.</URL>&gt;"
129,"<author><family>MEHRINFAR</family>, <given>R.</given>; <family>SHAH</family>, <given>A. P.</given></author>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title>, v. <volume>10</volume>, n. <issue>4</issue>, p. <page>267</page>, <issued><year>2009</year></issued>. <publisher>Elsevier BV</publisher>. Dispon√≠vel em: &lt;<URL>http://dx.doi.org/10.1016/j.carrev.2009.04.081</URL>&gt;. ."
130,"<author><family>MEHRINFAR</family>, <given>R.</given>; <family>SHAH</family>, <given>A. P.</given></author>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title>, [s. l.], v. <volume>10</volume>, n. <issue>4</issue>, p. <page>267</page>, <issued> <year>2009</year>.</issued>. Dispon√≠vel em: &lt;<URL>http://dx.doi.org/10.1016/j.carrev.2009.04.081</URL>&gt;"
131,"<author><family>MEHRINFAR</family>, <given>Ramona</given>; <family>SHAH</family>, <given>Atman Prabodh</given></author>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title>, [s. l.], v. <volume>10</volume>, n. <issue>4</issue>, p. <page>267</page>, <issued> <year>2009</year>.</issued>. Dispon√≠vel em: &lt;<URL>http://dx.doi.org/10.1016/j.carrev.2009.04.081</URL>&gt;"
132,"<author><family>MEHRINFAR</family>, <given>R.</given>; <family>SHAH</family>, <given>A. P.</given></author>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title>, v. <volume>10</volume>, n. <issue>4</issue>, p. <page>267</page>, <issued><month>Oct.</month> <year>2009</year></issued>. "
133,"<author><family>MEHRINFAR</family>, <given>R.</given>; <family>SHAH</family>, <given>A. P.</given></author>. <title>Bivalirudin versus Heparin and Eptifibatide in Patients Undergoing Rescue Percutaneous Coronary Intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title>, v. <volume>10</volume>, n. <issue>4</issue>, p. <page>267</page>, <issued><month>Oct.</month> <year>2009</year></issued>. Dispon√≠vel em: &lt;<URL>http://dx.doi.org/10.1016/j.carrev.2009.04.081</URL>&gt;."
134,"<author><family>MEHRINFAR</family>, <given>R.</given>; <family>SHAH</family>, <given>A. P.</given></author>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title>, v. <volume>10</volume>, n. <issue>4</issue>, p. <page>267</page>, <issued><month>Oct.</month> <year>2009</year></issued>. "
135,"<author><family>Mehrinfar</family>, <given>R.</given>, and <family>Shah</family>, <given>A. P.</given></author>. (<issued><year>2009</year></issued>) <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title>, <volume>10</volume>(<issue>4</issue>), <page>267</page>. doi:<DOI>10.1016/j.carrev.2009.04.081</DOI>"
136,"<author><family>Mehrinfar</family>, <given>R.</given> & <family>Shah</family>, <given>A. P.</given></author>, (<issued><year>2009</year></issued>), <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>, <container-title>Cardiovascular Revascularization Medicine</container-title>, vol. <volume>10</volume>, n¬∞<issue>4</issue>, p. <page>267</page>."
137,"<author><given>Ramona</given> <family>Mehrinfar</family> and <given>Atman Prabodh</given> <family>Shah</family></author>. <issued><year>2009</year></issued>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title>, <volume>10</volume>(<issue>4</issue>):<page>267</page>, <issued><month>October</month></issued>."
138,"<author><given>Ramona</given> <family>Mehrinfar</family> and <given>Atman Prabodh</given> <family>Shah</family></author>. <issued><year>2009</year></issued>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume>, <issue>4</issue> (<issued>October 2009</issued>), <page>267</page>. DOI:https://doi.org/<DOI>10.1016/j.carrev.2009.04.081</DOI>"
139,"<title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>.<author><family>Mehrinfar</family> <given>R</given>, <family>Shah</family> <given>AP</given></author>.<container-title>Cardiovascular Revascularization Medicine</container-title>. <issued><year>2009</year></issued> ; <volume>10</volume>(<issue>4</issue>) : <page>267</page>."
140,"<author><family>Mehrinfar</family> <given>R.</given> & <family>Shah</family> <given>A. P.</given></author> (<issued><year>2009</year></issued>) <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume> , <page>267</page>. [online]. Available from: <URL>http://dx.doi.org/10.1016/j.carrev.2009.04.081</URL>."
141,"<author><family>Mehrinfar</family> <given>Ramona</given>, <family>Shah</family> <given>Atman Prabodh</given></author>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <issued><year>2009</year></issued>;<volume>10</volume>(<issue>4</issue>):<page>267</page>, Doi: <DOI>10.1016/j.carrev.2009.04.081</DOI>."
142,"<author><family>Mehrinfar</family>, <given>Ramona</given> and <given>Atman Prabodh</given> <family>Shah</family></author>, <title>‚ÄúBivalirudin versus Heparin and Eptifibatide in Patients Undergoing Rescue Percutaneous Coronary Intervention‚Äù</title> (<issued>2009</issued>) <volume>10</volume>(<issue>4</issue>) <container-title>Cardiovascular Revascularization Medicine</container-title> <page-first>267</page-first> &lt;<URL>http://dx.doi.org/10.1016/j.carrev.2009.04.081</URL>&gt;"
143,"<author><family>Mehrinfar</family>, <given>R.</given>, and <family>Shah</family>, <given>A.P.</given></author> <issued><year>2009</year></issued>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume>, <page>267</page>."
144,"<author><family>Mehrinfar</family>, <given>R.</given> and <family>Shah</family>, <given>A.P.</given></author>, (<issued><year>2009</year></issued>) <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume>, <page>267</page>."
145,"<author><family>Mehrinfar</family> <given>R</given>, <family>Shah</family> <given>AP</given></author>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <publisher>Elsevier BV</publisher>, <issued><year>2009</year></issued>;<volume>10</volume>:<page>267</page>. <URL>http://dx.doi.org/10.1016/j.carrev.2009.04.081</URL>."
146,"<author><family>Mehrinfar</family>/<family>Shah</family></author>, <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>, <container-title>Cardiovascular Revascularization Medicine</container-title> <issued><year>2009</year></issued>, <page>267</page>"
147,"    <author><family>Mehrinfar</family>, <given>R.</given>, and <given>A. P.</given> <family>Shah</family></author>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume>: <page>267</page>. <issued><year>2009</year></issued>."
148,"<author><family>Mehrinfar</family>, <given>R.</given> & <family>Shah</family>, <given>A.P.</given></author>. (<issued><year>2009</year></issued>). <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title>, <volume>10</volume>, <page>267</page>. <publisher>Elsevier BV</publisher>. Retrieved from <URL>http://dx.doi.org/10.1016/j.carrev.2009.04.081</URL>"
149,"<author><family>Mehrinfar</family> <given>R</given>, <family>Shah</family> <given>AP</given></author>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <issued><year>2009</year></issued>; <volume>10</volume>:<page>267</page>. Retrieved from <URL>http://dx.doi.org/10.1016/j.carrev.2009.04.081</URL>"
150,"<author><family>Mehrinfar</family>, <given>Ramona</given>; <family>Shah</family>, <given>Atman Prabodh</given></author>, <title>‚ÄúBivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention,‚Äù</title> <container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume>, <issue>4</issue> (<issued><month>october</month> <year>2009</year></issued>), <publisher>Elsevier BV</publisher>, p. <page>267</page>, <URL>http://dx.doi.org/10.1016/j.carrev.2009.04.081</URL>."
151,"<author><family>Mehrinfar</family> <given>R</given>, <family>Shah</family> <given>AP</given></author>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> [Internet]. <publisher>Elsevier BV</publisher>; <issued><year>2009</year></issued>;<volume>10</volume>(<issue>4</issue>): <page>267</page>. DOI: <DOI>10.1016/j.carrev.2009.04.081</DOI>"
152,"<author><family>Mehrinfar</family>, <given>R.</given> & <family>Shah</family>, <given>A.P.</given></author> (<issued><year>2009</year></issued>). <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>&amp;#8211; <container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume>: <page>267</page>."
153,"<author><family>Mehrinfar</family>, <given>R.</given>/<family>Shah</family>, <given>A.¬†P.</given></author> (<issued>2009</issued>): <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. In: <container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume>, p. <page>267</page>."
154,"<author><family>Mehrinfar</family>, <given>Ramona</given>, and <given>Atman Prabodh</given> <family>Shah</family></author>.     <issued><year>2009</year></issued>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume>(<issue>4</issue>): <page>267</page>. DOI: <DOI>10.1016/j.carrev.2009.04.081</DOI>."
155,"<author><family>Mehrinfar</family> <given>R.</given>, <family>Shah</family> <given>A.P.</given></author> (<issued><year>2009</year></issued>), <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>, <container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume>(<issue>4</issue>):<page>267</page>. Retrieved from <URL>http://dx.doi.org/10.1016/j.carrev.2009.04.081</URL>"
156,"<author><family>Mehrinfar</family>, <given>R.</given> and <family>Shah</family>, <given>A. P.</given></author>. (<issued><year>2009</year></issued>) <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title>, <publisher>Elsevier BV</publisher> <volume>10</volume>, <page>267</page>."
157,"<author><family>Mehrinfar</family> <given>R</given>, <family>Shah</family> <given>AP</given></author>. <issued>(<year>2009</year>) </issued><title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> [Internet]. <volume>10</volume>, <page>267</page>. Available from: <URL>http://dx.doi.org/10.1016/j.carrev.2009.04.081</URL>"
158," <author><given>R.</given> <family>Mehrinfar</family>, <given>A. P.</given> <family>Shah</family></author> <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. (<issued><year>2009</year></issued>) <container-title>Cardiovascular Revascularization Medicine</container-title>. <volume>10</volume>, <page>267</page>. "
159,"<author><family>Mehrinfar</family>, <given>R.</given>, and <family>Shah</family>, <given>A. P.</given></author>. (<issued><year>2009</year></issued>) <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume>, <page>267</page>."
160,"<author><given>R.</given> <family>Mehrinfar</family>, <given>A.P.</given> <family>Shah</family></author>, <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>, <container-title>Cardiovascular Revascularization Medicine</container-title>, <volume>10</volume> (<issued><year>2009</year></issued>) <page>267</page>."
161,"<author><family>Mehrinfar</family> <given>R</given>, <family>Shah</family> <given>AP</given></author>. <issued><year>2009</year></issued>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume>:<page>267</page>. <URL>http://dx.doi.org/10.1016/j.carrev.2009.04.081</URL>."
162,"<author><family>Mehrinfar</family> <given>R</given>, <family>Shah</family> <given>AP</given></author><issued>. <year>2009</year>. </issued> <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume>: <page>267</page>. "
163,"<author><family>Mehrinfar</family>,<given>R.</given> and <family>Shah</family>,<given>A.P.</given></author> (<issued><year>2009</year></issued>) <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title>, <volume>10</volume>, <page>267</page>."
164,<author><family>Mehrinfar</family> <given>R.</given> & <family>Shah</family> <given>A.P.</given></author> <issued><year>2009</year></issued>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title>. <volume>10</volume>: <page>267</page>. 
165,"<author><family>Mehrinfar</family> <given>R</given>, <family>Shah</family> <given>AP</given></author>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title>, <volume>10</volume>, <page>267</page> (<issued><year>2009</year></issued>)."
166,<author><family>Mehrinfar</family> <given>R</given> & <family>Shah</family> <given>AP</given></author>. <issued><year>2009</year></issued>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume>: <page>267</page>.
167,"<author><family>Mehrinfar</family> <given>R</given>, <family>Shah</family> <given>AP</given></author> (<issued><year>2009</year></issued>): <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title>. <volume>10</volume>: <page>267</page>."
168,"<author><family>Mehrinfar</family>, <given>R.</given> & <family>Shah</family>, <given>A.P.</given></author> (<issued><year>2009</year></issued>) <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume>, <page>267</page>. <publisher>Elsevier BV</publisher>."
169,"<author><family>Mehrinfar</family> <given>R</given>, <family>Shah</family> <given>AP</given></author>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <issued><year>2009</year></issued>; <volume>10</volume>:<page>267</page>."
170,"<author><family>Mehrinfar</family> <given>R</given>, <family>Shah</family> <given>AP</given></author>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title>. <issued>2009</issued>;<volume>10</volume>:<page>267</page>. doi:<DOI>10.1016/j.carrev.2009.04.081</DOI>."
171,"<author><given>R.</given> <family>Mehrinfar</family> and <given>A.P.</given> <family>Shah</family></author>: <title>‚ÄúBivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention.‚Äù</title> <container-title>Cardiovascular Revascularization Medicine</container-title>. vol. <volume>10</volume>, no. 4, pp. <page>267</page>, <issued><year>2009</year></issued>."
172,"<author><family>Mehrinfar</family>, <given>R.</given> and <family>Shah</family>, <given>A.P.</given></author>. (<issued><year>2009</year></issued>) <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title>, <volume>10</volume>, <page>267</page>."
173,"<author><family>Mehrinfar</family>, <given>R.</given>, and <given>A.P.</given> <family>Shah</family></author>. <issued><year>2009</year></issued>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title>. <volume>10</volume>: <page>267</page>."
174,"<author><family>Mehrinfar</family>, <given>R.</given>; <family>Shah</family>, <given>A. P.</given></author>. <container-title>Cardiovascular Revascularization Medicine</container-title> <issued><year>2009</year></issued>, <volume>10</volume>, <page>267</page>."
175,"<author><family>Mehrinfar</family>, <given>R.</given>, and <family>Shah</family>, <given>A. P.</given></author>. (<issued><year>2009</year></issued>). <title>‚ÄúBivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention,‚Äù</title> <container-title>Cardiovascular Revascularization Medicine</container-title>, <publisher>Elsevier BV</publisher>, <volume>10</volume>(<issue>4</issue>), <page>267</page>. DOI: <DOI>10.1016/j.carrev.2009.04.081</DOI>"
176,"<author><family>Mehrinfar</family>, <given>R.</given> & <family>Shah</family>, <given>A.P.</given></author> (<issued><year>2009</year></issued>) <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume>(<issue>4</issue>), <page>267</page>."
177,"<author><family>MEHRINFAR</family>, <given>R.</given> & <family>SHAH</family>, <given>A.P.</given></author>. <issued><year>2009</year></issued>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume>(<issue>4</issue>):<page>267</page>."
178,"<author><family>Mehrinfar</family>, <given>R.</given>, and <given>A.P.</given> <family>Shah</family></author>. <issued><year>2009</year></issued>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume>:<page>267</page>"
179,"<author><family>Mehrinfar</family> <given>R</given>, <family>Shah</family> <given>AP</given></author>. <issued><year>2009</year></issued>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume>:<page>267</page>. <URL>http://dx.doi.org/10.1016/j.carrev.2009.04.081</URL>."
180,"<author><family>Mehrinfar</family>, <given>R.</given>, and <given>A. P.</given> <family>Shah</family></author>. <issued><year>2009</year></issued>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume>: <page>267</page>. Available at: <URL>http://dx.doi.org/10.1016/j.carrev.2009.04.081</URL>."
181,"<author><family>Mehrinfar</family>, <given>Ramona</given> and <family>Shah</family>, <given>Atman Prabodh</given></author> (<issued>2009</issued>): <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. ‚Äì <container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume>, <page>267</page>."
182,"<author><family>Mehrinfar</family> <given>R</given>, <family>Shah</family> <given>AP</given></author>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title>. <issued><year>2009</year></issued>;<volume>10</volume>(<issue>4</issue>):<page>267</page>. "
183,"<author><family>Mehrinfar</family> <given>R</given>, <family>Shah</family> <given>AP</given></author>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <issued><year>2009</year></issued>;<volume>10</volume>:<page>267</page>. doi:<DOI>10.1016/j.carrev.2009.04.081</DOI>"
184,"<author><family>Mehrinfar</family>, <given>R.</given> and <given>A.P.</given> <family>Shah</family></author> (<issued><year>2009</year></issued>) <title>‚ÄúBivalirudin versus Heparin and Eptifibatide in Patients Undergoing Rescue Percutaneous Coronary Intervention‚Äù</title>, <container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume> (<issue>4</issue>): <page>267</page>."
185,"<author><family>Mehrinfar</family> <given>R</given>, <family>Shah</family> <given>AP</given></author>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <issued>2009</issued>; <volume>10</volume>: <page>267</page>."
186,<author><family>Mehrinfar</family> <given>R.</given> & <family>Shah</family> <given>A.P.</given></author>. <issued><year>2009</year></issued>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume>: <page>267</page>.
187,"<author><family>Mehrinfar</family> <given>R</given>, <family>Shah</family> <given>AP</given></author>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <issued><year>2009</year></issued>;<volume>10</volume>:<page>267</page>. https://doi.org<DOI>10.1016/j.carrev.2009.04.081</DOI>."
188,"<author><family>Mehrinfar</family> <given>R</given>, <family>Shah</family> <given>AP</given></author> (<issued><year>2009</year></issued>): <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title><container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume>:<page>267</page>. "
189,"<author><family>Mehrinfar</family> <given>R</given>, <family>Shah</family> <given>AP</given></author>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title> [Internet]. <container-title>Cardiovascular Revascularization Medicine</container-title> <issued><year>2009</year></issued>; <volume>10</volume>: <page>267</page>.Available from: <URL>http://dx.doi.org/10.1016/j.carrev.2009.04.081</URL>"
190,"<author><family>Mehrinfar</family> <given>R</given>., <family>Shah</family> <given>AP</given>.</author> <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title>. <issued><year>2009</year></issued>;<volume>10</volume>(<issue>4</issue>):<page>267</page>. Doi: <DOI>10.1016/j.carrev.2009.04.081</DOI>."
191,"<author><family>Mehrinfar</family>, <given>R.</given> and <family>Shah</family>, <given>A.P.</given></author>: <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>, <container-title>Cardiovascular Revascularization Medicine</container-title>, <volume>10</volume> (<issued><year>2009</year></issued>), no. <issue>4</issue>, p. <page>267</page>."
192,"<author><family>Mehrinfar</family> <given>R</given>, <family>Shah</family> <given>AP</given></author>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <issued><year>2009</year></issued>; <volume>10</volume>:<page>267</page>"
193,"<author><family>Mehrinfar</family> <given>R</given>, <family>Shah</family> <given>AP</given></author>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> [Internet] <publisher>Elsevier BV</publisher>; <issued><year>2009</year></issued>; <volume>10</volume>: <page>267</page> Available from: <URL>http://dx.doi.org/10.1016/j.carrev.2009.04.081</URL>"
194,"<author><family>Mehrinfar</family> <given>R</given>, <family>Shah</family> <given>AP</given></author> (<issued><year>2009</year></issued>) <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume>: <page>267</page>, doi:<DOI>10.1016/j.carrev.2009.04.081</DOI>."
195,"<author><family>Mehrinfar</family> <given>R</given>, <family>Shah</family> <given>AP</given></author>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <issued><year>2009</year></issued>; <volume>10</volume>:<page>267</page>."
196,"<author><family>Mehrinfar</family>, <given>R.</given> & <family>Shah</family>, <given>A.P.</given></author> (<issued><year>2009</year></issued>) <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title>, <volume>10</volume>, <page>267</page> Available at: <URL>http://dx.doi.org/10.1016/j.carrev.2009.04.081</URL>."
197,"<author><family>Mehrinfar</family>, <given>R.</given> and <family>Shah</family>, <given>A. P.</given></author> (<issued><year>2009</year></issued>). <title>‚ÄúBivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention.‚Äù</title> <container-title>Cardiovascular Revascularization Medicine</container-title>. <volume>10</volume> (<issue>4</issue>): <page>267</page>. <URL>http://dx.doi.org/10.1016/j.carrev.2009.04.081</URL>."
198,"<author><family>Mehrinfar</family>, <given>R.</given>, and <family>Shah</family>, <given>A.P.</given></author> (<issued><year>2009</year></issued>). <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume>: <page>267</page>."
199,"<author><family>Mehrinfar</family>, <given>Ramona</given>, and <given>Atman Prabodh</given> <family>Shah</family></author>. <issued><year>2009</year></issued>. <title>Bivalirudin versus Heparin and Eptifibatide in Patients Undergoing Rescue Percutaneous Coronary Intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> <volume>10</volume>:<page>267</page>. Available at <URL>http://dx.doi.org/10.1016/j.carrev.2009.04.081</URL>, accessed."
200,"<author><family>Mehrinfar</family> <given>R</given>, <family>Shah</family> <given>AP</given></author>. <title>Bivalirudin versus heparin and eptifibatide in patients undergoing rescue percutaneous coronary intervention</title>. <container-title>Cardiovascular Revascularization Medicine</container-title> [Internet]. <publisher>Elsevier BV</publisher>; <issued><year>2009</year> <month>Oct</month></issued>; <volume>10</volume>: <page>267</page>. Available from: <URL>http://dx.doi.org/10.1016/j.carrev.2009.04.081</URL>"